Caring Brands, Inc. Common Stock
Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; CB-101 (Eczema Treatment) for atopic dermatitis (eczema); NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagn… Read more
Caring Brands, Inc. Common Stock (CABR) - Net Assets
Latest net assets as of September 2025: $2.60 Million USD
Based on the latest financial reports, Caring Brands, Inc. Common Stock (CABR) has net assets worth $2.60 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.17 Million) and total liabilities ($572.07K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.60 Million |
| % of Total Assets | 81.96% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Caring Brands, Inc. Common Stock - Net Assets Trend (2023–2024)
This chart illustrates how Caring Brands, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Caring Brands, Inc. Common Stock (2023–2024)
The table below shows the annual net assets of Caring Brands, Inc. Common Stock from 2023 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $3.69 Million | +1488.92% |
| 2023-12-31 | $-265.77K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Caring Brands, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 59701700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $4.55 Million | 123.37% |
| Total Equity | $3.69 Million | 100.00% |
Caring Brands, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Caring Brands, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
The Goodheart-Willcox Company Inc
PINK:GWOX
|
$4.03 Million |
|
Ilyda SA
AT:ILYDA
|
$4.03 Million |
|
G-Yen Hutong Co., Ltd.
TWO:2761
|
$4.03 Million |
|
Questor Technology Inc
PINK:QUTIF
|
$4.03 Million |
|
New England Realty Associates LP
NYSE MKT:NEN
|
$4.03 Million |
|
New Concept Energy Inc
NYSE MKT:GBR
|
$4.02 Million |
|
Polwax SA
WAR:PWX
|
$4.02 Million |
|
Pharma-Bio Serv Inc
OTCQB:PBSV
|
$4.02 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Caring Brands, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -265,774 to 3,691,376, a change of 3,957,150.
- Net loss of 1,517,400 reduced equity.
- Other factors increased equity by 5,474,550.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.52 Million | -41.11% |
| Other Changes | $5.47 Million | +148.31% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Caring Brands, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.72x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | $-0.02 | $0.97 | x |
| 2024-12-31 | $0.26 | $0.97 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Caring Brands, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -41.11%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -326322.58%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.05x
- Recent ROE (-41.11%) is below the historical average (-20.55%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | 0.00% | -627.23% | 0.89x | 0.00x | $-101.51K |
| 2024 | -41.11% | -326322.58% | 0.00x | 1.05x | $-1.89 Million |
Industry Comparison
This section compares Caring Brands, Inc. Common Stock's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Caring Brands, Inc. Common Stock (CABR) | $2.60 Million | 0.00% | 0.22x | $4.03 Million |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |